GoodRx Holdings (GDRX) stock forecast for 2026. Forecast tables and graphs.







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

GoodRx Holdings (GDRX) stock forecast for 2026

Updated: April 16, 2024 (14:04)

Sector: Healthcare

The share price of GoodRx Holdings, Inc. (GDRX) now

What analysts predict: $8.76
52-week High/Low: $9.37 / $4.135

50/200 Day Moving Average: $6.83 / $6.32

This figure corresponds to the Average Price over the previous 50/200 days. For GoodRx Holdings stocks, the 50-day moving average is the resistance level today.

For GoodRx Holdings stocks, the 200-day moving average is the resistance level today.

Are you interested in GoodRx Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GoodRx Holdings stock price in 2026. How much will one GoodRx Holdings share be worth in 2026? Is it worth taking profit / loss on GDRX stock now or waiting? What are analysts' forecasts for GoodRx Holdings stock?

We forecast GoodRx Holdings stock performance using neural networks based on historical data on GDRX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

GoodRx Holdings, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for GoodRx Holdings analysts is $8.76. Today 200 Day Moving Average is the support level (6.32 $). 50 Day Moving Average is the support level (6.83 $).




Historical and forecast chart of GoodRx Holdings, Inc. stock

The chart below shows the historical price of GoodRx Holdings stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GDRX stock price can be found in the table below.


GoodRx Holdings IPO will take place on September 22, 2020. The company is a developer of a platform that collects various data from 70 thousand pharmacies and compares drug prices to find cheaper ones. The placement underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays.

ABOUT IPO, SHAREHOLDERS AND PURCHASE OF GOODRX

Among the company’s shareholders are Silver Lake with a 35.3% stake (33.8% after the IPO), Francisco Partners with a 23.7% stake (22.1% after the IPO), Spectrum with a 15.4% stake (12 , 5% after the IPO) and Idea Men with a share of 17.9 %% (15.6% after the IPO). Silver Lake will IPO $ 100 million in Class A shares in a private placement that will take place concurrently with the IPO. In total, the company is placing 34.615 million shares, of which 23.4 million shares are sold by the company itself and 11.192 million – by the company’s shareholders. Throughout its history, the company has made two acquisitions – Iodine (a company that helps patients select the right drugs) in January 2017 and HeyDoctor (a telemedicine provider) in September 2019.

GoodRx Holdings (GDRX) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 7.49 7.24 7.68 5.85 %
Feb 7.76 7.39 8.41 12.07 %
Mar 7.19 6.67 7.45 10.42 %
Apr 7.08 6.91 7.65 9.76 %
May 7.91 7.69 8.34 7.74 %
Jun 8.02 7.31 8.73 16.31 %
Jul 7.79 7.18 8.30 13.41 %
Aug 7.38 7.11 7.89 9.87 %
Sep 7.62 7.28 8.33 12.62 %
Oct 7.52 6.91 8.05 14.12 %
Nov 7.65 7.28 8.19 11.11 %
Dec 7.33 6.65 7.77 14.38 %

GoodRx Holdings information and performance

GoodRx Holdings Address

233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US

Market Capitalization: 2 697 829 000 $

Market capitalization of the GoodRx Holdings, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GDRX shares in the company outstanding by the market price of one share.

EBITDA: 66 991 000 $

EBITDA of GoodRx Holdings is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.02

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 6.63
Quarterly Revenue Growth YOY: 0.068
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 20.49

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.647

Enterprise Value (EV) /Revenue

EV To EBITDA: 25.15

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 93266000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

GoodRx Holdings price target for 2026 by month


Target values for the price of one GoodRx Holdings share for Jan 2026.

The weighted average target price per GoodRx Holdings share in Jan 2026 is: 7.49.
In Jan, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 5.846% volatility is expected.
Pessimistic target level: 7.24
Optimistic target level: 7.68

Target values for the price of one GoodRx Holdings share for Feb 2026.

The weighted average target price per GoodRx Holdings share in Feb 2026 is: 7.76.
In Feb, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 12.066% volatility is expected.
Pessimistic target level: 7.39
Optimistic target level: 8.41

Target values for the price of one GoodRx Holdings share for Mar 2026.

The weighted average target price per GoodRx Holdings share in Mar 2026 is: 7.19.
In Mar, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 10.425% volatility is expected.
Pessimistic target level: 6.67
Optimistic target level: 7.45

Target values for the price of one GoodRx Holdings share for Apr 2026.

The weighted average target price per GoodRx Holdings share in Apr 2026 is: 7.08.
In Apr, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 9.763% volatility is expected.
Pessimistic target level: 6.91
Optimistic target level: 7.65

Target values for the price of one GoodRx Holdings share for May 2026.

The weighted average target price per GoodRx Holdings share in May 2026 is: 7.91.
In May, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 7.742% volatility is expected.
Pessimistic target level: 7.69
Optimistic target level: 8.34

Target values for the price of one GoodRx Holdings share for Jun 2026.

The weighted average target price per GoodRx Holdings share in Jun 2026 is: 8.02.
In Jun, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 16.311% volatility is expected.
Pessimistic target level: 7.31
Optimistic target level: 8.73

Target values for the price of one GoodRx Holdings share for Jul 2026.

The weighted average target price per GoodRx Holdings share in Jul 2026 is: 7.79.
In Jul, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 13.411% volatility is expected.
Pessimistic target level: 7.18
Optimistic target level: 8.30

Target values for the price of one GoodRx Holdings share for Aug 2026.

The weighted average target price per GoodRx Holdings share in Aug 2026 is: 7.38.
In Aug, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 9.873% volatility is expected.
Pessimistic target level: 7.11
Optimistic target level: 7.89

Target values for the price of one GoodRx Holdings share for Sep 2026.

The weighted average target price per GoodRx Holdings share in Sep 2026 is: 7.62.
In Sep, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 12.619% volatility is expected.
Pessimistic target level: 7.28
Optimistic target level: 8.33

Target values for the price of one GoodRx Holdings share for Oct 2026.

The weighted average target price per GoodRx Holdings share in Oct 2026 is: 7.52.
In Oct, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 14.120% volatility is expected.
Pessimistic target level: 6.91
Optimistic target level: 8.05

Target values for the price of one GoodRx Holdings share for Nov 2026.

The weighted average target price per GoodRx Holdings share in Nov 2026 is: 7.65.
In Nov, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 11.107% volatility is expected.
Pessimistic target level: 7.28
Optimistic target level: 8.19

Target values for the price of one GoodRx Holdings share for Dec 2026.

The weighted average target price per GoodRx Holdings share in Dec 2026 is: 7.33.
In Dec, the Negative dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 14.377% volatility is expected.
Pessimistic target level: 6.65
Optimistic target level: 7.77



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.